The treatment of locally advanced pancreatic cancer: a practice guideline.

Author: , AgboolaOlusegun, EarleCraig C, MarounJean, ZurawLisa

Paper Details 
Original Abstract of the Article :
BACKGROUND: Pancreatic adenocarcinoma is the fourth most common cause of adult cancer death. About 50% of patients present with metastatic disease, 20% with resectable disease and the remaining 30% of patients are diagnosed with incurable, locally advanced unresectable but nonmetastatic pancreatic c...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1155/2003/410276

データ提供:米国国立医学図書館(NLM)

Locally Advanced Pancreatic Cancer: Navigating a Difficult Terrain

Pancreatic cancer is a formidable disease, and locally advanced cases pose a significant challenge for healthcare providers. This study provides a practice guideline for the treatment of locally advanced pancreatic cancer, offering recommendations based on the latest scientific evidence.

The authors conducted a comprehensive review of the literature, including randomized controlled trials and practice guidelines, to identify the most effective treatments for locally advanced pancreatic cancer. Their analysis revealed that combined chemotherapy and radiotherapy offer the best chance of survival for suitable patients. The guideline recommends using 5-fluorouracil, a common chemotherapy drug, in combination with radiotherapy.

A Roadmap for Combating Pancreatic Cancer

This practice guideline serves as a valuable roadmap for healthcare professionals treating locally advanced pancreatic cancer. It provides evidence-based recommendations for treatment strategies, potentially improving patient outcomes and quality of life.

Facing the Desert of Pancreatic Cancer

This research is like a camel caravan venturing into a harsh and unforgiving desert – the fight against locally advanced pancreatic cancer is challenging and demanding. This study provides a guide for navigating this difficult terrain, offering the best chance of survival for patients.

Dr. Camel's Conclusion

This study offers a glimmer of hope in the vast desert of pancreatic cancer, providing a roadmap for treating locally advanced cases with the best chance of survival.

Date :
  1. Date Completed 2003-06-23
  2. Date Revised 2019-06-07
Further Info :

Pubmed ID

12677264

DOI: Digital Object Identifier

10.1155/2003/410276

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.